Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
Dawn Q. Chong, Andrew X. Zhu
Oncotarget (2016) Vol. 7, Iss. 29, pp. 46750-46767
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Molecular Pathogenesis of Cholangiocarcinoma
Peter Labib, George Goodchild, Stephen P. Pereira
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 256
Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review
Audra Boscoe, Catherine Rolland, Robin Kate Kelley
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 751-765
Open Access | Times Cited: 162
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
Domenico Alvaro, Gregory J. Gores, Joël Walicki, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 181-208
Open Access | Times Cited: 140
Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis
Gábor Lendvai, Tímea Szekerczés, Idikó Illyés, et al.
Pathology & Oncology Research (2018) Vol. 26, Iss. 1, pp. 3-15
Closed Access | Times Cited: 92
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
Simone Brivio, Massimiliano Cadamuro, Mario Strazzabosco, et al.
World Journal of Hepatology (2017) Vol. 9, Iss. 9, pp. 455-455
Open Access | Times Cited: 83
The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma
Massimiliano Cadamuro, Tommaso Stecca, Simone Brivio, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2017) Vol. 1864, Iss. 4, pp. 1435-1443
Open Access | Times Cited: 69
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response
Chao‐Yuan Huang, Feng‐Shu Hsieh, Cheng‐Yi Wang, et al.
European Journal of Cancer (2018) Vol. 102, pp. 10-22
Closed Access | Times Cited: 61
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism
Qingxin Zhou, Meihua Lin, Xing Feng, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 8
Open Access | Times Cited: 56
The new insight of treatment in Cholangiocarcinoma
Yuhang Li, Yinghui Song, Sulai Liu
Journal of Cancer (2022) Vol. 13, Iss. 2, pp. 450-464
Open Access | Times Cited: 31
Emerging Therapies in Management of Cholangiocarcinoma
Jessica Speckart, Veronica Rasmusen, Zohray Talib, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 613-613
Open Access | Times Cited: 7
The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer
Hwajeong Lee, Jeffrey S. Ross
Therapeutic Advances in Gastroenterology (2017) Vol. 10, Iss. 6, pp. 507-520
Open Access | Times Cited: 56
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
Domenico Alvaro, Cesare Hassan, Vincenzo Cardinale, et al.
Digestive and Liver Disease (2020) Vol. 52, Iss. 11, pp. 1282-1293
Closed Access | Times Cited: 48
Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells
Methi Wathikthinnakon, Piriya Luangwattananun, Nunghathai Sawasdee, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice
Yan Yang, Jiale Wang, Jianhua Wan, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 120-134
Closed Access | Times Cited: 5
The emerging role of mast cells in liver disease
Veronica Jarido, Lindsey Kennedy, Laura Hargrove, et al.
AJP Gastrointestinal and Liver Physiology (2017) Vol. 313, Iss. 2, pp. G89-G101
Open Access | Times Cited: 44
Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma
Nan Xie, Jia‐Bin Cai, Lu Zhang, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 12
Open Access | Times Cited: 42
Current biologics for treatment of biliary tract cancers
Diana Yi Zhao, Kian‐Huat Lim
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 3, pp. 430-440
Open Access | Times Cited: 41
FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
Paulina Chmiel, Katarzyna Gęca, Karol Rawicz‐Pruszyński, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3929-3929
Open Access | Times Cited: 22
Tumoral Intraductal Neoplasms of the Bile Ducts Comprise Morphologically and Genetically Distinct Entities
Tao Wang, Gokce Askan, Kerem Özcan, et al.
Archives of Pathology & Laboratory Medicine (2023) Vol. 147, Iss. 12, pp. 1390-1401
Open Access | Times Cited: 12
CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells
Qian Guo, Zhixiang Jian, Baoqing Jia, et al.
Oncology Reports (2016) Vol. 37, Iss. 2, pp. 1114-1122
Open Access | Times Cited: 34
Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion
Judit Kocsis, Anita Árokszállási, Csilla András, et al.
Journal of Gastrointestinal Oncology (2017) Vol. 8, Iss. 2, pp. E32-E38
Open Access | Times Cited: 34
Role of the Notch signaling in cholangiocarcinoma
Antonio Cigliano, Jingxiao Wang, Xin Chen, et al.
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 5, pp. 471-483
Closed Access | Times Cited: 34
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Angela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
Medicines (2020) Vol. 7, Iss. 9, pp. 54-54
Open Access | Times Cited: 28
Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
Zijian Zhang, Yun-peng Huang, Zhongtao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Discovering new interaction between genes in extrahepatic Cholangiocarcinoma using Bayesian networks
Fatemeh Salboukh, Aria Jahanimoghadam, Yashar Mousavi
Network Modeling Analysis in Health Informatics and Bioinformatics (2025) Vol. 14, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top